Wednesday, December 8, 2021
HomeBusinessBreakthrough Therapies Market Insights, Overview, Analysis and Forecast 2020 to 2026

Breakthrough Therapies Market Insights, Overview, Analysis and Forecast 2020 to 2026

The breakthrough therapies market is segmented on the lines of its application and regional. The basis of application the market is segmented into Oncology, Infectious Diseases, Rare Diseases, Autoimmune Diseases, Pulmonary Diseases, and Neurological Disorders. The breakthrough therapies market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Browse Full Report:

Rising number of molecules gaining BT status along with increasing number of cancer patients requiring therapies and drugs used to treat rare disease is predicted to boost the global breakthrough therapies industry size over the forecast period. Upsurge in prevalence of cancer and high spending in healthcare will further accelerate the business growth.

Developed region with better reimbursement policies and infrastructure will favour the industry growth over the coming years. As per European Federation of Pharmaceutical Industries and Associations, diseases relevant to nervous system, digestive system, respiratory system, cancer, and cardiovascular system are the major reasons for death in Europe.

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche, Novartis International AG, Regeneron, Acadia, Boehringer Ingelheim, GlaxoSmithKline, Vertex, Alexion, Merck, and Takeda. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.

Report scope:

The scope of the report includes a detailed study of breakthrough therapies market with the reasons given for variations in the growth of the industry in certain regions.

The top company reports are intended to provide our buyers with a snapshot of the industry’s most influential players.

Competitive Rivalry

Roche, Novartis International AG, Regeneron, Acadia, Boehringer Ingelheim, GlaxoSmithKline, Vertex, Alexion, Merck, and Takeda are among the major players in the global breakthrough therapies market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Breakthrough Therapies Market has been segmented as below:

The Breakthrough Therapies Marketis segmented on the lines ofBreakthrough Therapies Market, By Application and Breakthrough Therapies Market, By Region.

Breakthrough Therapies Market, By Applicationthis market is segmented on the basis ofInfectious Diseases, Rare Diseases, Autoimmune Diseases, Pulmonary Diseases and Neurological Disorders. Breakthrough Therapies Market, By Regionthis market is segmented on the basis ofNorth America, Europe, Asia Pacific and Rest of World.

The report covers:

  • An overview of the global breakthrough therapies market and related technologies
  • Analyses of global market trends, with actual data for 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2024
  • Identifications of new market opportunities and targeted promotional plans for breakthrough therapies market
  • Discussion of research and development, and the demand for new products and new applications.
  • Comprehensive company profiles of major players in the industry.

Reasons to Buy this Report:

  • Obtain the most up to date information available on the breakthrough therapies market
  • Identify growth segments and opportunities in the industry
  • Facilitate decision making on the basis of strong historic and forecast for breakthrough therapies market
  • Assess your competitor’s refining portfolio and its evolution

Request Sample Report from here:

Table of Contents:

  1.  Introduction
  2.  Research Methodology
  3.  Executive Summary
  4.  Market Overview
     4.1.    Introduction
    4.2.    Drivers
    4.2.1.    Rising number of drugs gaining BT status
    4.2.2.    Expedited approval process adopted in Europe
    4.3.    Restraints
    4.3.1.    High price of BT drugs
    4.4.    Opportunities
    4.4.1.    Growth in developed regions owing to better reimbursement policies
    4.5.    Challenges
    4.5.1.    Shifting preference for generics
  5.  Breakthrough Therapies Market, By Application
  6.  Competitive Landscape
  7.  Company Profile
     7.1.    Roche
    7.1.1.    Company Overview
    7.1.2.    Product/Service Landscape
    7.1.3.    Financial Overview
    7.1.4.    Recent Developments
    7.2.    Novartis International AG
    7.2.1.    Company Overview
    7.2.2.    Product/Service Landscape
    7.2.3.    Financial Overview
    7.2.4.    Recent Developments
    7.3.    Regeneron
    7.3.1.    Company Overview
    7.3.2.    Product/Service Landscape
    7.3.3.    Financial Overview
    7.3.4.    Recent Developments
    7.4.    Acadia
    7.4.1.    Company Overview
    7.4.2.    Product/Service Landscape
    7.4.3.    Financial Overview
    7.4.4.    Recent Developments
    7.5.    Boehringer Ingelheim
    7.5.1.    Company Overview
    7.5.2.    Product/Service Landscape
    7.5.3.    Financial Overview
    7.5.4.    Recent Developments
    7.6.    GlaxoSmithKline
    7.6.1.    Company Overview
    7.6.2.    Product/Service Landscape
    7.6.3.    Financial Overview
    7.6.4.    Recent Developments
    7.7.    Vertex
    7.7.1.    Company Overview
    7.7.2.    Product/Service Landscape
    7.7.3.    Financial Overview
    7.7.4.    Recent Developments
    7.8.    Alexion
    7.8.1.    Company Overview
    7.8.2.    Product/Service Landscape
    7.8.3.    Financial Overview
    7.8.4.    Recent Developments
    7.9.    Merck
    7.9.1.    Company Overview
    7.9.2.    Product/Service Landscape
    7.9.3.    Financial Overview
    7.9.4.    Recent Developments
    7.10.    Takeda
    7.10.1.    Company Overview
    7.10.2.    Product/Service Landscape
    7.10.3.    Financial Overview
    7.10.4.    Recent Developments
    7.11.    Pfizer
    7.11.1.    Company Overview
    7.11.2.    Product/Service Landscape
    7.11.3.    Financial Overview
    7.11.4.    Recent Developments


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [email protected]

Phone: +1-855-984-1862

Country: United States


wiliam saxena
Wiliam is from content strategy department. He has a keen eye for any new development that could rock our world. He is adept at strategizing to boost web traffic. He is also an expert in Google Analytics, something which he feels could go a long way in getting sites more traction by providing necessary insights.

Most Popular